Post

MSF Access
@msfaccess.org

NEW EVIDENCE: Analogue #insulin is associated with improved management & regulation of blood sugar levels for people with #diabetes. Data from two new studies in low- and middle-income countries, including those affected by humanitarian crises, below. 👇

MSF Access
@msfaccess.org

Luo et al (2026), in the HumAn-1 trial, conducted in Bangladesh and Tanzania, found “participants in the [insulin analogue] group spent less time in the very low range [hypoglycaemia] and had a reduced number of nocturnal hypoglycaemic events.” www.thelancet.com/journals/lan...

thelancet.comHuman versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trialAt 6 months, children and young people with type 1 diabetes living in low-resource settings randomly assigned to glargine had no evidence of effects on time in very low range and time in target range ...
MSF Access
@msfaccess.org

Together, these studies strengthen the evidence base on the benefits of analogue insulin, especially for people living with diabetes in low-resource and humanitarian settings. To improve diabetes care globally, analogue insulins must be accessible and affordable for all.